Moexipril detailed information: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Protected "Moexipril detailed information": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 28: Line 28:
{{CMG}}
{{CMG}}


{{EH}}
 


'''Moexipril''' (marketed under the tradenames '''Univasc''' and '''Perdix''') is an [[ACE inhibitor]].
'''Moexipril''' (marketed under the tradenames '''Univasc''' and '''Perdix''') is an [[ACE inhibitor]].
Line 36: Line 36:


{{ACE inhibitors}}
{{ACE inhibitors}}
{{SIB}}
 


[[Category:ACE inhibitors]]
[[Category:ACE inhibitors]]

Revision as of 17:29, 9 August 2012

Moexipril detailed information
Clinical data
Pregnancy
category
  • US: D (Evidence of risk)
Routes of
administration		Oral
ATC code
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC27H34N2O7
Molar mass498.568 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Moexipril (marketed under the tradenames Univasc and Perdix) is an ACE inhibitor.



Template:ACE inhibitors

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Moexipril_detailed_information&oldid=679771"